Correlation Between Jinhe Biotechnology and Zhongrun Resources

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Jinhe Biotechnology and Zhongrun Resources at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Jinhe Biotechnology and Zhongrun Resources into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Jinhe Biotechnology Co and Zhongrun Resources Investment, you can compare the effects of market volatilities on Jinhe Biotechnology and Zhongrun Resources and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Jinhe Biotechnology with a short position of Zhongrun Resources. Check out your portfolio center. Please also check ongoing floating volatility patterns of Jinhe Biotechnology and Zhongrun Resources.

Diversification Opportunities for Jinhe Biotechnology and Zhongrun Resources

-0.19
  Correlation Coefficient

Good diversification

The 3 months correlation between Jinhe and Zhongrun is -0.19. Overlapping area represents the amount of risk that can be diversified away by holding Jinhe Biotechnology Co and Zhongrun Resources Investment in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Zhongrun Resources and Jinhe Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Jinhe Biotechnology Co are associated (or correlated) with Zhongrun Resources. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Zhongrun Resources has no effect on the direction of Jinhe Biotechnology i.e., Jinhe Biotechnology and Zhongrun Resources go up and down completely randomly.

Pair Corralation between Jinhe Biotechnology and Zhongrun Resources

Assuming the 90 days trading horizon Jinhe Biotechnology Co is expected to under-perform the Zhongrun Resources. But the stock apears to be less risky and, when comparing its historical volatility, Jinhe Biotechnology Co is 1.22 times less risky than Zhongrun Resources. The stock trades about -0.04 of its potential returns per unit of risk. The Zhongrun Resources Investment is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  383.00  in Zhongrun Resources Investment on October 25, 2024 and sell it today you would earn a total of  30.00  from holding Zhongrun Resources Investment or generate 7.83% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Jinhe Biotechnology Co  vs.  Zhongrun Resources Investment

 Performance 
       Timeline  
Jinhe Biotechnology 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Jinhe Biotechnology Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, Jinhe Biotechnology is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Zhongrun Resources 

Risk-Adjusted Performance

20 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Zhongrun Resources Investment are ranked lower than 20 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zhongrun Resources sustained solid returns over the last few months and may actually be approaching a breakup point.

Jinhe Biotechnology and Zhongrun Resources Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Jinhe Biotechnology and Zhongrun Resources

The main advantage of trading using opposite Jinhe Biotechnology and Zhongrun Resources positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Jinhe Biotechnology position performs unexpectedly, Zhongrun Resources can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Zhongrun Resources will offset losses from the drop in Zhongrun Resources' long position.
The idea behind Jinhe Biotechnology Co and Zhongrun Resources Investment pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope